Activating Compound | Comment | Organism | Structure |
---|---|---|---|
acyldepsipeptide | allow the protease to degrade folded native proteins in the absence of its cognate chaperones | Escherichia coli |
Application | Comment | Organism |
---|---|---|
medicine | ClpP as antibacterial drug target | Escherichia coli |
medicine | ClpP as antibacterial drug target | Streptococcus pneumoniae |
medicine | ClpP as antibacterial drug target | Mycobacterium tuberculosis |
medicine | ClpP as antibacterial drug target | Plasmodium falciparum |
Crystallization (Comment) | Organism |
---|---|
ClpP structures have been solved from five different organisms | Escherichia coli |
ClpP structures have been solved from five different organisms | Streptococcus pneumoniae |
ClpP structures have been solved from five different organisms | Mycobacterium tuberculosis |
ClpP structures have been solved from five different organisms | Plasmodium falciparum |
ClpP structures have been solved from five different organisms, human ClpP can form a complex with Escherichia coli ClpX in vitro | Homo sapiens |
Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|
300000 | - |
- |
Escherichia coli |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Escherichia coli | - |
- |
- |
Homo sapiens | - |
- |
- |
Mycobacterium tuberculosis | - |
- |
- |
Plasmodium falciparum | - |
- |
- |
Streptococcus pneumoniae | - |
- |
- |
Subunits | Comment | Organism |
---|---|---|
heptamer | - |
Homo sapiens |
tetradecamer | - |
Escherichia coli |
tetradecamer | - |
Streptococcus pneumoniae |
tetradecamer | - |
Mycobacterium tuberculosis |
tetradecamer | - |
Plasmodium falciparum |
Synonyms | Comment | Organism |
---|---|---|
Clp protease | - |
Escherichia coli |
Clp protease | - |
Homo sapiens |
Clp protease | - |
Streptococcus pneumoniae |
Clp protease | - |
Mycobacterium tuberculosis |
Clp protease | - |
Plasmodium falciparum |
Clp proteolytic subunit | - |
Escherichia coli |